Oral platelet IIb/IIIa inhibitors: from attractive theory to clinical failures.
Gurbel
P A
PA
Sinai Center for Thrombosis Research, Baltimore, Maryland 21215, USA. Heartdrug@aol.com
Serebruany
V L
VL
D000208:Acute Disease; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000592:standards; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex